In massive intestinal resection models, BPC-157 prevented brain lesions that normally occur alongside intestinal adaptation, maintained normal weight gain, and prevented behavioral disturbances
The increased risk may relate to rapid weight loss, changes in gallbladder motility, or alterations in bile acid composition
FOXO4-DRI disrupts this interaction, freeing p53 to initiate apoptosis
From a regulatory standpoint, MOTS-c is classified as a research peptide in most jurisdictions and is not FDA-approved for any indication
Find out more from this WebMD slideshow
Pernicious anemia, one of the causes of vitamin B12 deficiency, is an autoimmune condition that prevents your body from absorbing vitamin B12